ENDRA Life Sciences (NDRA) Operating Expenses (2016 - 2026)

ENDRA Life Sciences (NDRA) has 11 years of Operating Expenses data on file, last reported at $2.2 million in Q1 2026.

• Operating Expenses for Q1 2026 came in at $2.2 million, up 47.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.5 million (down 31.96% YoY), and the FY2025 annual result was $5.8 million, down 46.72% from the prior year.
• Operating Expenses grew to $2.2 million in Q1 2026 per NDRA's latest filing, from $1.6 million in the prior quarter.
• Over five years, Operating Expenses peaked at $4.3 million in Q4 2024 and troughed at $1.3 million in Q2 2025.
• A 5-year average of $2.5 million and a median of $2.8 million in 2024 frame the typical range for Operating Expenses.
• The sharpest annual moves came in 2024 and 2025: Operating Expenses jumped 194.75% in 2024, then plunged 62.25% in 2025.
• A 5-year view of Operating Expenses shows it stood at $3.3 million in 2022, then plunged by 56.0% to $1.5 million in 2023, then jumped by 194.75% to $4.3 million in 2024, then sank by 62.25% to $1.6 million in 2025, then surged by 34.01% to $2.2 million in 2026.
• Business Quant data shows NDRA's Operating Expenses at $2.2 million in Q1 2026, $1.6 million in Q4 2025, and $1.4 million in Q3 2025.